Envista (NYSE:NVST) Reaches New 52-Week High – Should You Buy?

Shares of Envista Holdings Corporation (NYSE:NVST) hit a new 52-week high on Wednesday . The company traded as high as $24.25 and last traded at $24.22, with a volume of 2140295 shares trading hands. The stock had previously closed at $23.23.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on NVST shares. Weiss Ratings reiterated a “sell (d)” rating on shares of Envista in a report on Monday, December 29th. Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a research note on Saturday. JPMorgan Chase & Co. boosted their price objective on Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 16th. Robert W. Baird set a $27.00 target price on shares of Envista in a report on Friday, October 31st. Finally, Barclays assumed coverage on shares of Envista in a research note on Monday, December 8th. They issued an “overweight” rating and a $24.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Envista presently has a consensus rating of “Hold” and a consensus price target of $21.77.

Envista Stock Performance

The firm has a 50 day moving average of $21.19 and a two-hundred day moving average of $20.69. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 2.02. The stock has a market cap of $3.98 billion, a PE ratio of 268.85, a PEG ratio of 1.04 and a beta of 0.99.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.27 by $0.05. The company had revenue of $669.90 million for the quarter, compared to analyst estimates of $639.49 million. Envista had a net margin of 0.58% and a return on equity of 5.90%. The firm’s revenue was up 11.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.12 earnings per share. Research analysts predict that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

Hedge Funds Weigh In On Envista

Several large investors have recently bought and sold shares of NVST. GAMMA Investing LLC grew its holdings in shares of Envista by 34.3% during the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock worth $51,000 after purchasing an additional 638 shares during the last quarter. Claret Asset Management Corp grew its stake in Envista by 6.5% during the 2nd quarter. Claret Asset Management Corp now owns 11,827 shares of the company’s stock worth $231,000 after buying an additional 724 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Envista by 35.3% during the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,041 shares of the company’s stock worth $62,000 after buying an additional 793 shares during the period. Farther Finance Advisors LLC lifted its stake in Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after buying an additional 1,026 shares during the last quarter. Finally, Vanguard Personalized Indexing Management LLC boosted its holdings in shares of Envista by 5.6% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 20,100 shares of the company’s stock valued at $393,000 after acquiring an additional 1,067 shares during the period.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.